Xiaochun Yu
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 0.5%
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
Papers in
- Oncology 48
- PARP inhibition in cancer therapy 28
- Cancer-related Molecular Pathways 16
- Co-authors
- Junjie ChenJiaxue WuHongtae KimLin-Yu LuChunjing BianMichael S.Y. HuenGeorges MerClaudia C.S. Chini
- Journals
- Journal of Biological Chemistry (11 papers)Nucleic Acids Research (6 papers)Molecular Cell (5 papers)Molecular and Cellular Biology (5 papers)Nature Communications (4 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Xiaochun Yu
96 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 2.8k
- Molecular Biology 7.1k
- Cancer Research 943
- Cell Biology 914
- Genetics 1.3k
Countries citing papers authored by Xiaochun Yu
This map shows the geographic impact of Xiaochun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Yu more than expected).
Fields of papers citing papers by Xiaochun Yu
This network shows the impact of papers produced by Xiaochun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Yu. The network helps show where Xiaochun Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaochun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 18 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 47 | |
| 7 | 2016 | 36 | |
| 8 | 2015 | 154 | |
| 9 | 2015 | 61 | |
| 10 | 2015 | 17 | |
| 11 | 2015 | 16 | |
| 12 | 2014 | 15 | |
| 13 | 2013 | 21 | |
| 14 | 2013 | 15 | |
| 15 | 2013 | 45 | |
| 16 | 2013 | 244 | |
| 17 | 2013 | 129 | |
| 18 | 2009 | 420 | |
| 19 | 2007 | 455 | |
| 20 | The BRCT Domain Is a Phospho-Protein Binding Domain Hit paper breakdown → | 2003 | 678 |
About Xiaochun Yu
Xiaochun Yu is a scholar working on Physiology, Oncology, Molecular Biology, Cancer Research and Genetics, having authored 101 papers that have together received 8.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (68 papers), PARP inhibition in cancer therapy (28 papers), CRISPR and Genetic Engineering (19 papers), Ubiquitin and proteasome pathways (17 papers), Cancer-related Molecular Pathways (16 papers), Genomics and Chromatin Dynamics (15 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (13 papers). The work is most often cited by research in Oncology (2.8k citations), Molecular Biology (7.1k citations), Cancer Research (943 citations), Cell Biology (914 citations) and Genetics (1.3k citations). Xiaochun Yu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Junjie Chen, Jiaxue Wu, Hongtae Kim, Lin-Yu Lu, Chunjing Bian, Michael S.Y. Huen, Georges Mer, Claudia C.S. Chini, Yibin Chen and Kay Minn. Their work appears in journals such as Journal of Biological Chemistry, Nucleic Acids Research, Molecular Cell, Molecular and Cellular Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.